During the study period, researchers monitored the 524,817 participants who did not previously have a substance use disorder to see whether they developed alcohol, cannabis, cocaine, nicotine, opioid, or other substance use disorders
Your medication works harder when your body is actively building and maintaining muscle
What BMI qualifies for GLP-1 treatment
So Reed opted for gastric sleeve surgery in 2023 and dropped more than 100 pounds
Use our TDEE calculator to set a target intake
Currently, there is insufficient evidence to support the use of GLP-1 in treating binge eating disorder, but some studies suggest it may be helpful.18 Ongoing assessment and open discussions about the risks are recommended for this population.19 Clinical Efficacy: Weight Management, Type 2 Diabetes, and Cardiovascular Protection Weight Management Weight loss remains a primary reason individuals begin GLP-1 medications, and the STEP clinical trial program has been instrumental in evaluating the efficacy of semaglutide 2.4 mg for chronic weight management across diverse populations, with study participants recruited from a wide range of countries
